August 18, 2009 -- Par Pharmaceutical Companies, Inc. today announced that its licensing partner, Aveva Drug Delivery Systems, has received final approval from the U.S. FDA for its ANDA for a clonidine transdermal system.
the details can be read here.
No comments:
Post a Comment